IFRX
InflaRx (IFRX)
NASDAQ
$2.03-$0.04 (-1.70%)
Price as of Jun 03, 2026 7:21 PM EDT
  • $142.4M
    Market Cap
  • 146.59%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
29,331
-82.31%
165,789
+162.79%
63,089
N/A
N/A
N/A
Cost of Revenue
7.3M
+119.10%
3.3M
+523.20%
532,262
N/A
N/A
N/A
Gross Profit
-7.2M
+129.70%
-3.2M
+571.66%
-469,173
N/A
0
N/A
Sales and Marketing Expense
4.5M
-33.66%
6.8M
+68.86%
4.0M
-73.09%
14.9M
+24.07%
Research and Development Expense
-25.7M
-27.27%
-35.4M
-13.80%
-41.0M
+9.32%
-37.5M
+5.12%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Total Operating Expenses
13.5M
+3.46%
13.0M
+3.13%
12.6M
-15.07%
14.9M
+24.07%
Operating Profit
N/A
N/A
N/A
N/A
-44.9M
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-2,692
+204.18%
-885
-94.65%
-16,538
-29.03%
-23,303
N/A
Interest Income and Expense and Net
-2,692
+204.18%
-885
-94.65%
-16,538
-29.03%
-23,303
N/A
Total Nonoperating Income and Expense
2.7M
-49.48%
5.3M
-60.00%
13.2M
-34.42%
20.2M
+37,079.63%
Income before Taxes
-45.6M
-0.93%
-46.1M
+7.96%
-42.7M
+44.71%
-29.5M
-35.38%
Income Taxes
12,282
+135.42%
5,217
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-45.6M
-0.93%
-46.1M
+7.96%
-42.7M
+44.71%
-29.5M
-35.38%
Net Income from Continuing Operations Applicable to Common
-45.6M
-0.93%
-46.1M
+7.96%
-42.7M
+44.71%
-29.5M
-35.38%
Basic EPS and Net Income
-0.68
-12.82%
-0.78
0.00%
-0.78
+16.42%
-0.67
N/A
Diluted EPS and Net Income
-0.68
-12.82%
-0.78
0.00%
-0.78
+16.42%
-0.67
N/A
Basic Weighted Average Shares
67.3M
+14.20%
58.9M
+7.24%
54.9M
+24.28%
44.2M
+6.19%
Diluted Weighted Average Shares
67.3M
+14.20%
58.9M
+7.24%
54.9M
+24.28%
44.2M
+6.19%
Balance Sheet
Cash and Cash Equivalents
16.0M
-12.81%
18.4M
+43.92%
12.8M
-21.50%
16.3M
-38.04%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
16.0M
-12.81%
18.4M
+43.92%
12.8M
-21.50%
16.3M
-38.04%
Total Current Assets
53.6M
-25.15%
71.7M
-34.54%
109.5M
+12.38%
97.4M
+1.81%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
289,317
+12.89%
256,280
-11.50%
289,577
-11.96%
328,920
+19.88%
Total Long-Term Assets
1.6M
-63.74%
4.4M
-59.39%
10.7M
+115.29%
5.0M
-83.07%
Total Assets
55.2M
-27.36%
76.0M
-36.76%
120.2M
+17.39%
102.4M
-18.17%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
13.0M
-8.36%
14.2M
-15.90%
16.8M
+29.31%
13.0M
-30.55%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
677,850
+55.49%
435,943
-44.30%
782,593
-23.59%
1.0M
-7.01%
Total Liabilities
13.7M
-6.46%
14.6M
-17.16%
17.6M
+25.46%
14.1M
-29.25%
Retained Earnings
-377.8M
+13.74%
-332.2M
+16.10%
-286.1M
+17.53%
-243.5M
+13.78%
Total Stockholders Equity
41.6M
-32.34%
61.4M
-40.13%
102.6M
+16.11%
88.3M
-16.08%
Total Shares Outstanding
72.3M
+21.80%
59.4M
+0.80%
58.9M
+31.72%
44.7M
+1.13%
Cash Flow
Cash from Operating Activities
-35.3M
-27.27%
-48.6M
+28.41%
-37.8M
+12.06%
-33.7M
-15.51%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
3.2M
-93.83%
52.4M
+395.90%
-17.7M
-191.42%
19.4M
+174.60%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
33.3M
+8,521.29%
386,446
-99.27%
53.0M
+2,634.83%
1.9M
-96.85%
Financials Ratio
Gross Margin
-24,677.94%
+1,198.32%
-1,900.76%
+155.59%
-743.67%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-71,182.13%
N/A
N/A
N/A
Return on Assets
-69.55%
+48.13%
-46.95%
+22.48%
-38.33%
N/A
N/A
N/A
Return on Equity
-88.63%
+57.77%
-56.18%
+25.69%
-44.69%
N/A
N/A
N/A
Revenue Growth
-82.31%
-150.56%
162.79%
N/A
N/A
N/A
N/A
N/A
Current Ratio
4.13
-18.32%
5.06
-22.17%
6.50
N/A
N/A
N/A
Cash Ratio
1.23
-4.85%
1.30
+71.12%
0.76
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow